PowerUp Acquisition amends merger with Visiox: Outside Date extended to June 30, 2024

Aspire Biopharma Holdings, Inc.

Outside Date moved from May 31 to June 30, 2024; PowerUp's indebtedness cap increased to $2M.
Net tangible asset test eliminated; minimum cash condition reduced from $5M to $1.00.
Visiox must use best efforts to complete labeling/compliance for inventory by June 30, 2024.
Visiox must raise at least $500K capital by June 30; $350K allocated to labeling project.
From May 30 to closing, Visiox cannot make expenditures over $1K without PowerUp's approval.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.